Companies

ALNYLAM PHARMACEUTICALS, INC. (ALNY) SEC filings

CIK 0001178670 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · fiscal year ends 12/31

Annual financials (from the company's own XBRL in its 10-K filings)

FY2025FY2024FY2022FY2021
Revenue (USD)3.7 B1.0 B
Net income (USD)-858.3 M-886.1 M
Diluted EPS (USD/shares)2.33-9.3

Latest filings

FiledFormDescriptionPeriod
2026-10-064PRIMARY DOCUMENT2026-10-02
2026-10-02144144
2026-09-224PRIMARY DOCUMENT2026-09-19
2026-07-3010-Q10-Q2026-06-30
2026-07-308-K8-K items 2.02,9.012026-07-30
2026-06-034PRIMARY DOCUMENT2026-06-01
2026-06-034PRIMARY DOCUMENT2026-06-01
2026-06-033PRIMARY DOCUMENT2026-06-01
2026-06-01144144
2026-05-278-K8-K items 5.02,5.072026-05-20
2026-05-224PRIMARY DOCUMENT2026-05-20
2026-05-224PRIMARY DOCUMENT2026-05-20
2026-05-224PRIMARY DOCUMENT2026-05-20
2026-05-224PRIMARY DOCUMENT2026-05-20
2026-05-224PRIMARY DOCUMENT2026-05-20
2026-05-224PRIMARY DOCUMENT2026-05-20
2026-05-224PRIMARY DOCUMENT2026-05-20
2026-05-224PRIMARY DOCUMENT2026-05-20
2026-05-224PRIMARY DOCUMENT2026-05-20
2026-05-144PRIMARY DOCUMENT2026-05-13
2026-05-14SCHEDULE 13G/ASCHEDULE 13G/A
2026-05-14SCHEDULE 13G/ASCHEDULE 13G/A
2026-05-06SCHEDULE 13G/ASCHEDULE 13G/A
2026-04-3010-Q10-Q2026-03-31
2026-04-308-K8-K items 2.02,9.012026-04-30

Forms on file (last 1,000): 4 561, 8-K 141, SC 13G/A 70, 144 48, 10-Q 36, 3 22, CT ORDER 18, DEF 14A 12. Source: SEC EDGAR, as filed; this page is public data and not investment advice.

For software and AI agents: the same data as JSON, per call, no account: GET https://store.agentexchange.work/gw/filings/company?ticker=ALNY (0.002 USD), /gw/filings/filings?ticker=ALNY&form=8-K, /gw/filings/facts?ticker=ALNY&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txt

Updated from EDGAR within 30 minutes of a filing. Agent Exchange